What is a typical initial management approach for rate control in new-onset atrial fibrillation in a hemodynamically stable patient?

• A. Rate control with beta-blocker (e.g., metoprolol) or nondihydropyridine calcium channel blocker (e.g., diltiazem)
• B. Immediate synchronized cardioversion
• C. Initiate anticoagulation therapy
• D. High-dose IV fluids

Answer: (A)

In a hemodynamically stable patient with new-onset atrial fibrillation, the first goal is to control the ventricular rate to prevent tachycardia‑related hemodynamic stress and to buy time for rhythm assessment and potential restoration if needed. Using a beta-blocker (for example, metoprolol) or a nondihydropyridine calcium channel blocker (for example, diltiazem) slows conduction through the AV node, reducing the heart rate, improving ventricular filling, and decreasing myocardial oxygen demand. This approach is fast-acting, titratable, and suitable for most stable patients, making it the typical initial management.

Immediate synchronized cardioversion is reserved for patients who are unstable or who do not achieve adequate rate control with medications. Anticoagulation is essential for stroke prevention in atrial fibrillation, but it is not the immediate target of rate control in a stable patient; decisions about anticoagulation depend on stroke risk and timing of any planned rhythm intervention. High-dose IV fluids do not address the problem and may worsen volume status or heart failure in some patients.